{
    "clinical_study": {
        "@rank": "146431", 
        "brief_summary": {
            "textblock": "In this registry study the investigators will collect data about patients' disease,\n      treatment, and response to treatment to include in both our local and national databases.\n      These can then be used by investigators to answer questions about cytoreductive\n      surgery/HIPEC such as how well-tolerated or effective it is in specific populations."
        }, 
        "brief_title": "HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis \u2010 Data Registry", 
        "completion_date": {
            "#text": "January 2034", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Peritoneal Neoplasms", 
            "Neoplasm Metastasis", 
            "Adenocarcinoma", 
            "Sarcoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Adenocarcinoma", 
                "Neoplasms", 
                "Neoplasm Metastasis", 
                "Peritoneal Neoplasms", 
                "Carcinoma", 
                "Sarcoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patient Selection:  The sole inclusion criteria for this study will be those consenting\n      patients who are to undergo cytoreductive surgery followed by HIPEC.\n\n      Data Collection and Use Plan:  For those patients who provide informed consent, data listed\n      below will be collected during and after treatment.  This will be entered into the PI's\n      local database for future use and, after being de-identified, will be shared with a national\n      database (held by the American Society of Peritoneal Surface Malignancies) to bolster the\n      amount available for researchers looking at efficacy and outcomes such as overall survival\n      rates, progression-free survival, and tolerability in certain populations.\n\n      Data Collected (as applicable):  Age, primary tumor, dates of prior surgeries, prior\n      chemotherapy with dates and whether it was neoadjuvant in nature, length of disease status,\n      comorbidities, Peritoneal Surface Disease Severity Score, Peritoneal Cancer Index as\n      determined prior to surgery, Peritoneal Cancer Index as determined during surgery,\n      Completeness of Cytoreduction score, ascites present, blood products used, complications,\n      length of stay in ICU and in hospital, where discharged, death within 30 days, readmission\n      and reason, date of recurrence, treatment of recurrence, and time from procedure to death.\n      For the HIPEC surgical procedure itself, data collected will be:  date, duration,\n      chemotherapeutic used and dose, duration of circulation, fluid temp, and flow rate."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Eligible to undergo cytoreductive surgery followed by HIPEC performed by the PI at\n             Edward Hospital\n\n          -  Provides consent by signing informed consent form\n\n        Exclusion Criteria:\n\n          -  Not eligible for surgery or for potential cytoreductive surgery and/or HIPEC as\n             determined by the PI\n\n          -  Does not consent to participate"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The sole inclusion criteria for this study will be those consenting patients who are to\n        undergo cytoreductive surgery followed by HIPEC performed by the PI at Edward Hospital."
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02082886", 
            "org_study_id": "EDW120613A"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Metastasis", 
            "Carcinomatosis", 
            "Carcinosis", 
            "Sarcomatosis", 
            "CRS", 
            "Cytoreductive surgery", 
            "HIPEC", 
            "Heated Intraperitoneal Chemotherapy", 
            "Intra-abdominal", 
            "Sugarbaker technique", 
            "Mitomycin C", 
            "Cisplatin", 
            "Doxorubicin", 
            "Oxaliplatin", 
            "Melphalan"
        ], 
        "lastchanged_date": "March 6, 2014", 
        "link": {
            "description": "Related Info", 
            "url": "http://www.edward.org/cancersurgery"
        }, 
        "location": {
            "contact": {
                "email": "DKovacevic@edward.org", 
                "last_name": "Daniela Kovacevic, RN", 
                "phone": "630-646-6024"
            }, 
            "facility": {
                "address": {
                    "city": "Naperville", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60540"
                }, 
                "name": "Edward Hospital"
            }, 
            "investigator": {
                "last_name": "George I Salti, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis \u2010 Data Registry", 
        "overall_contact": {
            "email": "DKovacevic@edward.org", 
            "last_name": "Daniela Kovacevic, RN", 
            "phone": "630-646-6024"
        }, 
        "overall_official": {
            "affiliation": "Edward Hospital", 
            "last_name": "George I Salti, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2034", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Collect data from patients undergoing CRS/HIPEC which will be used to examine overall survival rates in specific patient populations.", 
            "measure": "Overall survival rate", 
            "safety_issue": "No", 
            "time_frame": "From time of treatment until death, approximately 10 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02082886"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Collect data from patients undergoing CRS/HIPEC which will be used to examine progression-free survival rates in specific patient populations", 
                "measure": "Progression-free survival rate", 
                "safety_issue": "No", 
                "time_frame": "From time of treatment until time of disease progression, approximately 10 years"
            }, 
            {
                "description": "Collect data from patients to examine rates of complications in specific patient populations", 
                "measure": "Rates of complications", 
                "safety_issue": "No", 
                "time_frame": "During procedure until approximately 90 days post"
            }
        ], 
        "source": "Edward Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Edward Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "10 Years", 
        "verification_date": "March 2014"
    }
}